Bastide le Fair Value
BL
The fair market value of BLC.PA stock is 23.22 EUR. Relative to the market price of 17.68 EUR Bastide le is undervalued by 31.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Bastide le Valuation
Current BLC.PA share ticker price is 17.68 EUR.
The fair value level of 23.22 EUR can be considered as an effective entry point for long-term investors to start investing in BLC.PA stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 31% lower its fair value
Current price is 0% higher its minimum value
Current price is 114% lower its maximum value
Market price:
BLC.PA stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Bastide le Confort Medical SA Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
40.65
2
Median P/E over 5 years
24.94
3
Minimum P/E over 5 years
18.97
4
Earning per share (last 12 months)
0.93 EUR
Maximum value
1
x
4
=
37.84 EUR
Fair value
2
x
4
=
23.22 EUR
Minimum value
3
x
4
=
17.66 EUR
Bastide le Confort Medical SA price metrics
-14.5
Annual return (geometric mean)
34.56
Risk (standard deviation) of returns
β
1.2
Beta (volatility compared to market)